Aziyo Biologics Reports Highest Sales and Gross Profit in Company History

AZYODelisted Stock  USD 2.44  0.00  0.00%   
About 56% of Aziyo Biologics' investor base is looking to short. The analysis of current outlook of investing in Aziyo Biologics suggests that many traders are alarmed regarding Aziyo Biologics' prospects. Aziyo Biologics' investing sentiment overview a quick insight into current market opportunities from investing in Aziyo Biologics. Many technical investors use Aziyo Biologics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
- All Four Business Segments Achieved Growth Led by Strong SimpliDerm and CanGaroo Sales - SILVER SPRING, Md., May 10, 2023 Aziyo Biologics, Inc. , a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today provided a business update and reported financial results for the first quarter ended March 31, 2023. Business Highlights Net sales rose 14 percent compared to the pr

Read at finance.yahoo.com
Yahoo News
  

Aziyo Biologics Fundamental Analysis

We analyze Aziyo Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aziyo Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aziyo Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

Aziyo Biologics is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Aziyo Biologics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aziyo Biologics stock to make a market-neutral strategy. Peer analysis of Aziyo Biologics could also be used in its relative valuation, which is a method of valuing Aziyo Biologics by comparing valuation metrics with similar companies.

Peers

Aziyo Biologics Related Equities

NVNOEnVVeno Medical   0.71   
0%
11.0%
ESTAEstablishment Labs   0.63   
0%
9.0%
SRDXSurModics   0.10   
0%
1.0%
OFIXOrthofix Medical   0.72   
11.0%
0%
ANIKAnika Therapeutics   0.98   
15.0%
0%
IRIXIRIDEX   1.15   
18.0%
0%
ELMDElectromed   1.47   
23.0%
0%
AXGNAxogen   1.73   
27.0%
0%
AORTArtivion   1.93   
30.0%
0%
LNSRLENSAR   2.08   
32.0%
0%
AVNSAvanos Medical   2.55   
39.0%
0%
SSKNSTRATA Skin   2.60   
40.0%
0%
SGHTSight Sciences   3.76   
58.0%
0%
CVRXCVRx   4.25   
66.0%
0%
NXLNexalin Technology   4.81   
75.0%
0%
AIMDAinos   6.38   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Aziyo Stock

If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like